Acerca de Kymab ltd

Acerca de la compañía

Kymab, based in Cambridge, UK, is working independently and with partners to provide novel solutions in drug and vaccine development. Using our unique technology, we rapidly develop broad diversity, high-quality human antibodies for treating challenging diseases. We are building a rich pipeline of assets in four main therapeutic spaces: immuno-oncology, inflammation, haematology and infectious diseases, with clinical studies expected to begin in 2017.